T
TScan Therapeutics Inc
NASDAQ:TCRX
TScan Therapeutics Inc
NASDAQ:TCRX
Price:
1.13
USD
4.63%
Market Closed
Market Cap:
$64.1m
Balance Sheet
Balance Sheet Decomposition
TScan Therapeutics Inc
TScan Therapeutics Inc
Balance Sheet Decomposition is not available for
TScan Therapeutics Inc
TScan Therapeutics Inc
Balance Sheet
TScan Therapeutics Inc
TScan Therapeutics Inc
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
42
|
35
|
161
|
120
|
133
|
179
|
|
| Cash Equivalents |
42
|
35
|
161
|
120
|
133
|
179
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
59
|
111
|
|
| Other Current Assets |
1
|
2
|
4
|
4
|
2
|
3
|
|
| Total Current Assets |
42
|
36
|
166
|
124
|
194
|
293
|
|
| PP&E Net |
6
|
13
|
17
|
69
|
71
|
72
|
|
| PP&E Gross |
6
|
13
|
17
|
69
|
71
|
72
|
|
| Accumulated Depreciation |
1
|
2
|
5
|
10
|
15
|
19
|
|
| Long-Term Investments |
0
|
0
|
0
|
1
|
2
|
2
|
|
| Other Long-Term Assets |
1
|
1
|
5
|
5
|
5
|
5
|
|
| Total Assets |
49
N/A
|
50
+1%
|
188
+278%
|
199
+6%
|
272
+37%
|
371
+36%
|
|
| Liabilities | |||||||
| Accounts Payable |
1
|
3
|
2
|
3
|
2
|
4
|
|
| Accrued Liabilities |
1
|
4
|
7
|
10
|
14
|
20
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
3
|
0
|
|
| Other Current Liabilities |
0
|
11
|
12
|
4
|
11
|
12
|
|
| Total Current Liabilities |
2
|
17
|
21
|
17
|
30
|
36
|
|
| Long-Term Debt |
0
|
0
|
0
|
29
|
27
|
32
|
|
| Other Liabilities |
4
|
15
|
6
|
53
|
65
|
62
|
|
| Total Liabilities |
7
N/A
|
33
+378%
|
27
-16%
|
100
+265%
|
121
+22%
|
130
+7%
|
|
| Equity | |||||||
| Common Stock |
60
|
60
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
17
|
44
|
92
|
158
|
248
|
375
|
|
| Additional Paid In Capital |
0
|
1
|
253
|
258
|
398
|
616
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
43
N/A
|
17
-60%
|
161
+835%
|
99
-38%
|
151
+52%
|
241
+60%
|
|
| Total Liabilities & Equity |
49
N/A
|
50
+1%
|
188
+278%
|
199
+6%
|
272
+37%
|
371
+36%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
24
|
24
|
24
|
24
|
48
|
57
|
|
Switch to:
Switch to:
See Also
Discover More
